Lite Strategy IncLITS
Price$1.38

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $0TTM through 31 Mar 2026
Net Income -$58.1M+338.5% YoYTTM through 31 Mar 2026
Free Cash Flow -$10.4MTTM through 31 Mar 2026

Margins

Current
Gross Margin0.0%

Returns

-102.3%ROE
-100.6%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio11.53x
Net Debt-$7.5Mnet cash position
Cash & Equivalents$7.5M

Quality Metrics

Altman Z-Score15.65
Piotroski F-Score2 / 9
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $0
Diluted EPS-$2.08TTM
'19'20'21'22'23'24'25
FY2025: $-2.39

Dividend

No dividend

Capital Allocation

R&D Spend$169K

Segment Performance

SegmentRevenueYoYOutlook
Digital Asset Treasury$0
View details

The company plans to scale its covered call options program and continue executing its Litecoin treasury strategy.

Pharmaceutical Assets$0
View details

Provides unique strategic optionality independent of the digital asset treasury, with potential for out-licensing or sale.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.